Baseline characteristics of the Indian cohort from the IMPROVE study: a multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes (Q44786444)

From Wikidata
Jump to navigation Jump to search
scientific article published on 27 February 2009
edit
Language Label Description Also known as
English
Baseline characteristics of the Indian cohort from the IMPROVE study: a multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes
scientific article published on 27 February 2009

    Statements

    Baseline characteristics of the Indian cohort from the IMPROVE study: a multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes (English)
    Siddharth Shah
    Ajay Kumar
    A G Unnikrishnan
    M P Baruah
    B Ganapathi
    27 February 2009
    325-335

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit